Queen Mary Utilization of Antihypertensive Drugs Study: Side-effects of antihypertensive drugs

被引:14
作者
Cheung, BMY
Wong, YL
Lau, CP
机构
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Sch Profess & Continuing Educ, Hong Kong, Hong Kong, Peoples R China
[3] Univ Sunderland, Sunderland SR2 7EE, Durham, England
关键词
angiotensin-converting enzyme inhibitor; beta-blocker; calcium channel blocker; drug utilization; hypertension; thiazide diuretic;
D O I
10.1111/j.1365-2710.2005.00662.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objective: Effective prevention of cardiovascular events in hypertensive patients requires good control of blood pressure. Side-effects of antihypertensive drugs affect tolerability and compliance. Accordingly, we surveyed side-effects in the hypertension outpatient clinic. Methods: A total of 228 patients (109 men, 119 women) were interviewed in April-May 2004 in the Queen Mary Utilization of Antihypertensive Drugs Study. Results: The percentage of patients receiving no drug (life-style modification), one, two, three and over three drugs were 3, 30, 40, 22 and 6% respectively. The proportion of patients taking calcium channel blockers, beta-blockers (BB), angiotensin-converting enzyme inhibitors, thiazide diuretics, alpha-blockers and angiotensin receptor blockers were 65, 64, 33, 24, 4 and 7% respectively. Blood pressure on treatment was 144 +/- 21/82 +/- 11 mmHg. Among patients on antihypertensive drug therapy, 34% reported adverse effects: dizziness (9%), ankle swelling (7%), headache (5%), fatigue (4%), chest discomfort (3%) and cough (3%). Fewer patients on BBs reported side-effects (OR 0.46, P = 0.008). The likelihood of experiencing side-effects was unrelated to sex, age, weight, BMI, years of treatment, number of drugs used, heart rate on treatment or compliance. Conclusions: To achieve good blood pressure control, multiple drugs are used. Thiazides are underused whereas BBs are popular. The popularity of the latter may be related to its tolerability.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 36 条
[21]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[22]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[23]   2003 European society of hypertension -: European Society of Cardiology guidelines for the management of arterial hypertension [J].
Mancia, G ;
Rosei, EA ;
Cifkova, R ;
DeBacker, G ;
Erdine, S ;
Fagard, R ;
Farsang, C ;
Heagerty, AM ;
Kawecka-Jaszcs, K ;
Kiowski, W ;
Kjeldsen, S ;
Lüscher, T ;
McInnes, G ;
Mallion, JM ;
Brien, EO ;
Poulter, NR ;
Priori, SG ;
Rahn, KH ;
Rodicio, JL ;
Ruilope, LM ;
Safar, M ;
Staessen, JA ;
van Zwieten, P ;
Waeber, B ;
Williams, B ;
Zanchetti, A ;
Zannad, F .
JOURNAL OF HYPERTENSION, 2003, 21 (06) :1011-1053
[24]  
MEADE TW, 1992, BMJ-BRIT MED J, V304, P405
[25]   β-blockers in hypertension -: The emperor has no clothes:: An open letter to present and prospective drafters of new guidelines for the treatment of hypertension [J].
Messerli, FH ;
Beevers, DG ;
Franklin, SS ;
Pickering, TG .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (10) :870-873
[26]  
Neal B, 2000, LANCET, V356, P1955
[27]   Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials [J].
Pahor, M ;
Psaty, BM ;
Alderman, MH ;
Applegate, WB ;
Williamson, JD ;
Cavazzini, C ;
Furberg, CD .
LANCET, 2000, 356 (9246) :1949-1954
[28]  
PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556, DOI 10.1016/S0140-6736(01)06178-5
[29]   Cardiovascular protection and blood pressure reduction: a meta-analysis [J].
Staessen, JA ;
Wang, YG ;
Thijs, L .
LANCET, 2001, 358 (9290) :1305-1315
[30]   Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension [J].
Staessen, JA ;
Fagard, R ;
Thijs, L ;
Celis, H ;
Arabidze, GG ;
Birkenhager, WH ;
Bulpitt, CJ ;
deLeeuw, PW ;
Dollery, CT ;
Fletcher, AE ;
Forette, F ;
Leonetti, G ;
Nachev, C ;
OBrien, ET ;
Rosenfeld, J ;
Rodicio, JL ;
Tuomilehto, J ;
Zanchetti, A .
LANCET, 1997, 350 (9080) :757-764